Fish oil delays lymphoma progression in the TLL mouse

References

• Dy GK, Bekele L, Hanson LJ, et al.Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 2004;22:4810–4815.
   PubMed Web of Science ®Google Scholar
• Hensel M, Zoz M, Ho AD. Complementary and alternative medicine in patients with chronic lymphocytic leukemia. Support Care Cancer 2009;17:47–52.
   PubMed Web of Science ®Google Scholar
• Palakurthi SS, Fluckiger R, Aktas H, et al.Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res 2000;60:2919–2925.
   PubMed Web of Science ®Google Scholar
• Hardman WE. (n-3) fatty acids and cancer therapy. J Nutr 2004;134:3427S–3430S.
   PubMed Web of Science ®Google Scholar
• Lindskog M, Gleissman H, Ponthan F, Castro J, Kogner P, Johnsen JI. Neuroblastoma cell death in response to docosahexaenoic acid: sensitization to chemotherapy and arsenic-induced oxidative stress. Int J Cancer 2006;118:2584–2593.
   PubMed Web of Science ®Google Scholar
• Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2007;77:327–335.
   PubMed Web of Science ®Google Scholar
• Jolly CA, Jiang YH, Chapkin RS, McMurray DN. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. J Nutr 1997;127:37–43.
   PubMed Web of Science ®Google Scholar
• Switzer KC, McMurray DN, Morris JS, Chapkin RS. (n-3) Polyunsaturated fatty acids promote activation-induced cell death in murine T lymphocytes. J Nutr 2003;133:496–503.
   PubMed Web of Science ®Google Scholar
• Chow SC, Sisfontes L, Bjorkhem I, Jondal M. Suppression of growth in a leukemic T cell line by n-3 and n-6 polyunsaturated fatty acids. Lipids 1989;24:700–704.
   PubMed Web of Science ®Google Scholar
• MacLean CH, Mojica WA, Newberry SJ, et al.Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr 2005;82:611–619.
   PubMed Web of Science ®Google Scholar
• Harbige LS. Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 2003;38:323–341.
   PubMed Web of Science ®Google Scholar
• Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008;8:380–390.
   PubMed Web of Science ®Google Scholar
• Cheson BD. Clinical management of T-cell malignancies: current perspectives, key issues, and emerging therapies. Semin Oncol 2007;34:S3–S7.
   PubMed Web of Science ®Google Scholar
• Eriksson B, Johansson AS, Roos G, Levan G, Holmberg D. Establishment and characterization of a mouse strain (TLL) that spontaneously develops T-cell lymphomas/leukemia. Exp Hematol 1999;27:682–688.
   PubMed Web of Science ®Google Scholar
• Noren-Nystrom U, Eriksson M, Eriksson B, Roos G, Bergh A, Holmberg D. Antitumor activity of the angiogenesis inhibitor TNP-470 on murine lymphoma/leukemia cells in vivo and in vitro. Exp Hematol 2003;31:143–149.
   PubMed Web of Science ®Google Scholar
• Johansson AS, Eriksson M, Noren-Nystrom U, Larefalk A, Eriksson B, Holmberg D. Germ line insertions of moloney murine leukemia virus in the TLL mouse causes site-specific differences in lymphoma/leukemia frequency and tumor immunophenotype. Anticancer Res 2006;26:2873–2878.
   PubMed Web of Science ®Google Scholar
• Masztalerz A, Everse LA, Otter WD. Presence of cytotoxic B220+ CD3+ CD4-CD8- cells correlates with the therapeutic efficacy of lymphoma treatment with IL-2 and/or IL-12. J Immunother 2004;27:107–15.
   PubMed Web of Science ®Google Scholar
• Li Q, Teitz-Tennenbaum S, Donald EJ, Li M, Chang AE. In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy. J Immunol 2009;183:3195–3203.
   PubMed Web of Science ®Google Scholar
• Benatar T, Cao MY, Lee Y, et al.IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo. Cancer Immunol Immunother 2010;59:805–817.
   PubMed Web of Science ®Google Scholar
• Jackaman C, Cornwall S, Graham PT, Nelson DJ. CD40-activated B cells contribute to mesothelioma tumor regression. Immunol Cell Biol 2010 Jul 13. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Reisfeld RA, Gillies SD, Mendelsohn J, Varki NM, Becker JC. Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu/nu mice by an antibody-lymphotoxin fusion protein. Cancer Res 1996;56:1707–1712.
   PubMed Web of Science ®Google Scholar
• Mukaro VR, Costabile M, Murphy KJ, et al.Leukocyte numbers and function in subjects eating n-3 enriched foods: selective depression of natural killer cell levels. Arthritis Res Ther 2008;10:R57
   PubMed Web of Science ®Google Scholar
• Schwerbrock NM, Karlsson EA, Shi Q, et al.Fish oil-fed mice have impaired resistance to influenza infection. J Nutr 2009;139:1588–1594.
   PubMed Web of Science ®Google Scholar
• Mannini A, Kerstin N, Calorini L, Mugnai G, Ruggieri S. Dietary n-3 polyunsaturated fatty acids enhance metastatic dissemination of murine T lymphoma cells. Br J Nutr 2009;102:958–961.
   PubMed Web of Science ®Google Scholar
• Noonan DM, De Lerma Barbaro A, Vannini N, Mortara L, Albini A. Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev 2008;27:31–40.
   PubMed Web of Science ®Google Scholar
• Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al.Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma: a double-blind, randomized placebo-controlled study. Cancer 2000;88:1916–1928.
   PubMed Web of Science ®Google Scholar
• Iversen PO, Sorensen DR, Tronstad KJ, et al.A bioactively modified fatty acid improves survival and impairs metastasis in preclinical models of acute leukemia. Clin Cancer Res 2006;12:3525–3531.
   PubMed Web of Science ®Google Scholar
• Cha MC, Meckling KA, Stewart C. Dietary docosahexaenoic acid levels influence the outcome of arabinosylcytosine chemotherapy in L1210 leukemic mice. Nutr Cancer 2002;44:176–181.
   PubMed Web of Science ®Google Scholar
• Oth D, Mercier G, Tremblay P, et al.Modulation of CD4 expression on lymphoma cells transplanted to mice fed (n-3) polyunsaturated fatty acids. Biochim Biophys Acta 1990;1027:47–52.
   PubMed Web of Science ®Google Scholar
• Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995;87:1456–1462.
   PubMed Web of Science ®Google Scholar
• Rose DP, Hatala MA, Connolly JM, Rayburn J. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res 1993;53:4686–4690.
   PubMed Web of Science ®Google Scholar
• Polesel J, Talamini R, Montella M, et al.Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol 2006;17:713–718.
   PubMed Web of Science ®Google Scholar